PSI has completed acquisition of Thywill, a reputable CRO having its main offices in Buenos Aires, Argentina, and specializing in managing clinical trials throughout Latin America.
PSI is known and respected for consistently securing fast patient enrollment into clinical studies of all sizes and levels of complexity, across a broad range of indications. The addition of Argentina, Venezuela, Peru, Ecuador, Uruguay, Colombia, Chile and Mexico to PSI’s operational map further enhances the company’s core strengths.
PSI is a full-service CRO operating across Europe, Russia, North and South Americas. For more information visit www.psi-cro.com or contact Ginny Payeur at +1 (650) 592 9101 or firstname.lastname@example.org